These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 9816331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma.
    Younes E, Haas GP, Dezso B, Ali E, Maughan RL, Kukuruga MA, Montecillo E, Pontes JE, Hillman GG.
    Cell Immunol; 1995 Oct 15; 165(2):243-51. PubMed ID: 7553889
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 4. Radiation therapy enhances the therapeutic effect of immunotherapy on pulmonary metastases in a murine renal adenocarcinoma model.
    Chakrabarty A, Hillman GG, Maughan RL, Ali E, Pontes JE, Haas GP.
    In Vivo; 1994 Oct 15; 8(1):25-31. PubMed ID: 8054507
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans.
    Rubin JT, Elwood LJ, Rosenberg SA, Lotze MT.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7086-92. PubMed ID: 2582450
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Dec 15; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 9. A convenient cancer vaccine therapy with in vivo transfer of interleukin 12 expression plasmid using gene gun technology after priming with irradiated carcinoma cells.
    Nishitani MA, Sakai T, Ishii K, Zhang M, Nakano Y, Nitta Y, Miyazaki J, Kanayama HO, Kagawa S, Himeno K.
    Cancer Gene Ther; 2002 Feb 15; 9(2):156-63. PubMed ID: 11857033
    [Abstract] [Full Text] [Related]

  • 10. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
    Kroeze SG, Daenen LG, Nijkamp MW, Roodhart JM, de Gast GC, Bosch JL, Jans JJ.
    J Urol; 2012 Aug 15; 188(2):607-14. PubMed ID: 22704448
    [Abstract] [Full Text] [Related]

  • 11. Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil.
    Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, Muller S, Pericle F.
    Cancer Gene Ther; 2000 Aug 15; 7(8):1165-71. PubMed ID: 10975677
    [Abstract] [Full Text] [Related]

  • 12. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
    Iguchi M, Matsumoto M, Hojo K, Wada T, Matsuo Y, Arimura A, Abe K.
    Jpn J Clin Oncol; 2009 May 15; 39(5):303-9. PubMed ID: 19336449
    [Abstract] [Full Text] [Related]

  • 13. Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.
    Huang P, Kaku H, Chen J, Kashiwakura Y, Saika T, Nasu Y, Urata Y, Fujiwara T, Watanabe M, Kumon H.
    Cancer Gene Ther; 2010 Jul 15; 17(7):484-91. PubMed ID: 20168351
    [Abstract] [Full Text] [Related]

  • 14. Influence of tumor site on the therapy of murine kidney cancer.
    Chakrabarty A, Hillman GG, Maughan RL, Visscher DW, Ali E, Pontes JE, Haas GP.
    Anticancer Res; 1994 Jul 15; 14(2A):373-8. PubMed ID: 8017836
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 16. Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.
    Younes E, Haas GP, Visscher D, Pontes JE, Puri RK, Hillman GG.
    J Urol; 1995 Feb 15; 153(2):490-3. PubMed ID: 7815631
    [Abstract] [Full Text] [Related]

  • 17. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ.
    Cancer Res; 1991 Jul 15; 51(14):3741-7. PubMed ID: 1905975
    [Abstract] [Full Text] [Related]

  • 18. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H, Matsumoto A, Kitamura T, Takeuchi T.
    BJU Int; 2006 Jun 15; 97(6):1314-21. PubMed ID: 16686731
    [Abstract] [Full Text] [Related]

  • 19. Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma.
    Yockman JW, Kim WJ, Chang CW, Kim SW.
    Gene Ther; 2007 Oct 15; 14(19):1399-405. PubMed ID: 17653245
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.